//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...




Honoured to be a recipient in this incredible cohort: www.cancer.nsw.gov.au/research-and... Thank you CINSW! 🌟
Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out! @garvaninstitute.bsky.social www.science.org/doi/10.1126/...
Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances! www.science.org/doi/10.1126/...
Mar 20, 2025
Mar 14, 2025
Mar 26, 2025
Shona Ritchie
🥳 So happy to share I’ve been awarded a Cancer Institute NSW Fellowship! This will support my work on investigating metabolic perturbations in pancreatic cancer with the Timpson Lab @garvaninstitute.bsky.social @cancerecogarvan.bsky.social
Daniel Reed
Mar 20, 2025
MBSANZ
Had a fantastic time at @myueg.bsky.social week in Berlin, sharing science and meeting new colleagues/pals! Huge thanks to @metastasisresearch.bsky.social for making it possible for me to attend and share our research
8mo
Shona Ritchie
Shona Ritchie
Find out more about the recipients of the 2024 Career Support Grants and their research projects.
www.cancer.nsw.gov.au
2024 Career Support Funds Granted
Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.
www.science.org
Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis